Press release
Prostate Cancer Market Expected to Experience Major Growth by 2034, According to DelveInsight | Bayer, Johnson & Johnson Innovative Medicine (Janssen), Astellas Pharma, Pfizer, Janssen R&D
The Key Prostate Cancer Companies in the market include - Bayer, Johnson & Johnson Innovative Medicine (Janssen), Astellas Pharma, Pfizer, Janssen Research & Development/Tesaro, Sanofi, MacroGenics, Candel Therapeutics, Kangpu Biopharmaceuticals, Point Biopharma, AstraZeneca, Essa Pharma, and others.DelveInsight's "Prostate Cancer Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Prostate Cancer, historical and forecasted epidemiology as well as the Prostate Cancer market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
The latest healthcare forecast report provides an in-depth analysis of Prostate Cancer, offering comprehensive insights into the Prostate Cancer revenue trends, prevalence, and treatment landscape. The report delves into key Prostate Cancer statistics, highlighting the current and projected market size, while examining the efficacy and development of emerging Prostate Cancer therapies. Additionally, we cover the landscape of Prostate Cancer clinical trials, providing an overview of ongoing and upcoming studies that are poised to shape the future of Prostate Cancer treatment. This report is an essential resource for understanding the market dynamics and the evolving therapeutic options within the Prostate Cancer space.
To Know in detail about the Prostate Cancer market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Prostate Cancer Market Forecast [https://www.delveinsight.com/sample-request/prostate-cancer-market-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Some of the key facts of the Prostate Cancer Market Report:
*
The Prostate Cancer market size was valued ~USD 7,000 million in 2023 and is anticipated to grow with a significant CAGR during the study period (2020-2034)
*
In October 2024, A study showed that Johnson & Johnson's Erleada outperformed Astellas and Pfizer's Xtandi in real-world treatment of metastatic castration-sensitive prostate cancer (mCSPC). While Xtandi previously led the market, analysis of more than 3,700 patients found Erleada reduced the risk of death by 23% over Xtandi after 24 months. At that point, 88% of patients on Erleada remained alive, aligning with findings from the Phase 3 TITAN trial, compared to an 85% survival rate for Xtandi.
*
In September 2024, Ipsen reported that the Phase III CONTACT-02 trial evaluating Cabometyx Registered and atezolizumab for metastatic castration-resistant prostate cancer (mCRPC) showed a modest improvement in overall survival, though it was not statistically significant, while achieving its progression-free survival (PFS) endpoint.
*
In September 2024, Foundation Medicine has obtained FDA approval for its FoundationOne Registered CDx and Liquid CDx as companion diagnostic tools for identifying BRCA-mutated metastatic castration-resistant prostate cancer (mCRPC) patients eligible for treatment with Lynparza Registered .
*
In July 2024, The ARANOTE trial demonstrated that NUBEQA Registered combined with ADT significantly enhanced radiological progression-free survival (PFS) in patients with metastatic hormone-sensitive, castration-resistant prostate cancer (mHSPC).
*
In July 2024, The FDA has awarded fast-track designation to SYNC-T SV-102 for the treatment of metastatic castration-resistant prostate cancer (mCRPC).
*
In 2023, the United States accounted for the largest market share for metastatic castration-resistant prostate cancer (mCRPC) and metastatic castration-sensitive prostate cancer (mCSPC) within the 7MM, at 63% and 61%, respectively, with the EU4 and the UK following.
*
The current U.S. market for metastatic castration-resistant prostate cancer (mCRPC) includes therapies such as JEVTANA, ZYTIGA, XTANDI, XOFIGO, among others. In 2023, XTANDI held the largest market share, reaching approximately USD 2,800 million.
*
Key Prostate Cancer Companies: Bayer, Johnson & Johnson Innovative Medicine (Janssen), Astellas Pharma, Pfizer, Janssen Research & Development/Tesaro, Sanofi, MacroGenics, Candel Therapeutics, Kangpu Biopharmaceuticals, Point Biopharma, AstraZeneca, Essa Pharma, and others
*
Key Prostate Cancer Therapies: NUBEQA (darolutamide), ERLEADA (apalutamide), XTANDI (enzalutamide), AKEEGA (niraparib + abiraterone acetate + prednisone), JEVTANA + prednisone, MGC018 (vobramitamab duocarmazine), CAN-2409, KPG-121, 177Lu-PNT2002 (PNT2002), Capivasertib, CAN-2409 + valacyclovir + radiation therapy plus-minus ADT, MGC018, EPI-7386, and others
*
The Prostate Cancer market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Prostate Cancer pipeline products will significantly revolutionize the Prostate Cancer market dynamics.
*
According to DelveInsight's estimates, the total prevalent cases of prostate cancer in the 7MM reached approximately 8,241,400 in 2023; however, this number does not represent the treatable population. These cases are expected to grow over the forecast period from 2024 to 2034.
*
In 2023, the United States reported the highest prevalence of prostate cancer cases, with around 3,803,500 cases.
*
According to estimates, in 2023, the majority of prostate cancer cases in the US were diagnosed in individuals aged 65 to 74, representing nearly 40% of all cases.
*
In the US, the total diagnosed prevalent cases of prostate cancer in 2023 were highest in the locally advanced stages (Stage I-III), with more than 903,700 cases. This was followed by cases of biochemical recurrence/progression and metastatic cases.
Prostate Cancer Overview
Prostate cancer is a form of cancer that develops in the prostate, a small gland in men that produces seminal fluid, which nourishes and transports sperm. It typically grows slowly and may initially remain confined to the prostate, where it may not cause serious harm. However, certain types of prostate cancer can be aggressive and spread to other areas of the body, including bones and lymph nodes. Symptoms often include difficulty urinating, pelvic discomfort, and, in advanced cases, bone pain. Early detection through screenings, such as prostate-specific antigen (PSA) tests, can improve treatment outcomes.
Get a Free sample for the Prostate Cancer Market Forecast, Size & Share Analysis Report:
https://www.delveinsight.com/report-store/prostate-cancer-market-insight [https://www.delveinsight.com/report-store/prostate-cancer-market-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Prostate Cancer Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2020 to 2034. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.
Prostate Cancer Epidemiology Segmentation:
The Prostate Cancer market report proffers epidemiological analysis for the study period 2020-2034 in the 7MM segmented into:
*
Total Prevalence of Prostate Cancer
*
Prevalent Cases of Prostate Cancer by severity
*
Gender-specific Prevalence of Prostate Cancer
*
Diagnosed Cases of Episodic and Chronic Prostate Cancer
Download the report to understand which factors are driving Prostate Cancer epidemiology trends @ Prostate Cancer Epidemiology Forecast [https://www.delveinsight.com/sample-request/prostate-cancer-market-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Prostate Cancer Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Prostate Cancer market or expected to get launched during the study period. The analysis covers Prostate Cancer market uptake by drugs, patient uptake by therapies, and sales of each drug. Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share. The report also covers the Prostate Cancer Pipeline Development Activities.
It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Prostate Cancer Therapies and Key Companies
*
NUBEQA (darolutamide): Bayer
*
ERLEADA (apalutamide): Johnson & Johnson Innovative Medicine (Janssen)
*
XTANDI (enzalutamide): Astellas Pharma/Pfizer
*
AKEEGA (niraparib + abiraterone acetate + prednisone): Janssen Research & Development/Tesaro
*
JEVTANA + prednisone: Sanofi
*
MGC018 (vobramitamab duocarmazine): MacroGenics
*
CAN-2409: Candel Therapeutics
*
KPG-121: Kangpu Biopharmaceuticals
*
177Lu-PNT2002 (PNT2002): Point Biopharma
*
Capivasertib: AstraZeneca
*
CAN-2409 + valacyclovir + radiation therapy plus-minus ADT: Candel Therapeutics
*
MGC018: MacroGenics
*
EPI-7386: Essa Pharma
Discover more about therapies set to grab major Prostate Cancer market share @ Prostate Cancer Treatment Landscape [https://www.delveinsight.com/sample-request/prostate-cancer-market-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Prostate Cancer Market Drivers
*
Rising Incidence Rates
*
Advancements in Treatment Options
*
Increased Awareness and Screening
*
Government Initiatives
*
Innovative Diagnostic Techniques
Prostate Cancer Market Barriers
*
High Treatment Costs
*
Regulatory Challenges
*
Limited Awareness in Certain Populations
*
Adverse Effects of Treatments
*
Competition from Alternative Therapies
Scope of the Prostate Cancer Market Report
*
Study Period: 2020-2034
*
Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
*
Key Prostate Cancer Companies: Bayer, Johnson & Johnson Innovative Medicine (Janssen), Astellas Pharma, Pfizer, Janssen Research & Development/Tesaro, Sanofi, MacroGenics, Candel Therapeutics, Kangpu Biopharmaceuticals, Point Biopharma, AstraZeneca, Essa Pharma, and others
*
Key Prostate Cancer Therapies: NUBEQA (darolutamide), ERLEADA (apalutamide), XTANDI (enzalutamide), AKEEGA (niraparib + abiraterone acetate + prednisone), JEVTANA + prednisone, MGC018 (vobramitamab duocarmazine), CAN-2409, KPG-121, 177Lu-PNT2002 (PNT2002), Capivasertib, CAN-2409 + valacyclovir + radiation therapy plus-minus ADT, MGC018, EPI-7386, and others
*
Prostate Cancer Therapeutic Assessment: Prostate Cancer current marketed and Prostate Cancer emerging therapies
*
Prostate Cancer Market Dynamics: Prostate Cancer market drivers and Prostate Cancer market barriers
*
Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
*
Prostate Cancer Unmet Needs, KOL's views, Analyst's views, Prostate Cancer Market Access and Reimbursement
To know more about Prostate Cancer companies working in the treatment market, visit @ Prostate Cancer Clinical Trials and Therapeutic Assessment [https://www.delveinsight.com/sample-request/prostate-cancer-market-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Table of Contents
1. Prostate Cancer Market Report Introduction
2. Executive Summary for Prostate Cancer
3. SWOT analysis of Prostate Cancer
4. Prostate Cancer Patient Share (%) Overview at a Glance
5. Prostate Cancer Market Overview at a Glance
6. Prostate Cancer Disease Background and Overview
7. Prostate Cancer Epidemiology and Patient Population
8. Country-Specific Patient Population of Prostate Cancer
9. Prostate Cancer Current Treatment and Medical Practices
10. Prostate Cancer Unmet Needs
11. Prostate Cancer Emerging Therapies
12. Prostate Cancer Market Outlook
13. Country-Wise Prostate Cancer Market Analysis (2020-2034)
14. Prostate Cancer Market Access and Reimbursement of Therapies
15. Prostate Cancer Market Drivers
16. Prostate Cancer Market Barriers
17. Prostate Cancer Appendix
18. Prostate Cancer Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.
Media Contact
Company Name: DelveInsight
Contact Person: Gaurav Bora
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=prostate-cancer-market-expected-to-experience-major-growth-by-2034-according-to-delveinsight-bayer-johnson-johnson-innovative-medicine-janssen-astellas-pharma-pfizer-janssen-rd]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Prostate Cancer Market Expected to Experience Major Growth by 2034, According to DelveInsight | Bayer, Johnson & Johnson Innovative Medicine (Janssen), Astellas Pharma, Pfizer, Janssen R&D here
News-ID: 3787303 • Views: …
More Releases from ABNewswire

Apps4.Pro Migration Manager Transforms Microsoft 365 Tenant Migration: Zero Data …
Tirunelveli, India - 30 August, 2025 - When global enterprises need to migrate their Microsoft 365 environments, failure isn't an option. A single misstep can mean lost data, broken workflows, and frustrated teams. Today, Apps4.Pro-trusted by over 15,000 organizations worldwide-announces the enhanced Migration Manager platform that's redefining what's possible in tenant-to-tenant migration.
From Fortune 500 giants like Siemens Energy and Johnson & Johnson to fast-scaling startups, organizations are discovering a migration…

Dynamic Roofing Concepts Offers Roof Replacement in Brandon, FL as Aging Roofs I …
Brandon, FL - Homeowners in Brandon, Florida, are facing increased pressure to replace aging roofs as insurance companies tighten coverage requirements. Dynamic Roofing Concepts provides roof replacement in Brandon, FL [https://www.dynamicroofingconcepts.com/] and has seen increased demand as local homeowners face pressure from insurance companies to replace aging roofs.
In Florida, most homeowners are aware that old roofs are more vulnerable to wind and water damage. Insurance providers have responded by requiring…

How to Know When It's Time for an Exterminator: Evo Foam Pest Control's Expert G …
Not sure when to contact an exterminator? Evo Foam Pest Control explains the common signs of pest problems in Austin and why timely intervention is essential.
Austin, TX - Pest infestations can occur at any time, leaving homeowners in Austin, TX, wondering when it's necessary to call an exterminator Austin TX. With numerous pests, including ants, rodents, and termites, threatening the comfort of homes, it's essential to recognize the signs that…

Palm Coast Pest Control Shows How Eco-Friendly Pest Control Keeps Jupiter, FL Ho …
Discover how Palm Coast Pest Control uses eco-friendly solutions to protect Jupiter, FL homes from pests while maintaining a healthy, chemical-free environment.
Jupiter, FL - As residents of Jupiter, FL, seek effective and sustainable solutions to pest problems, Palm Coast Pest Control stands out as a trusted provider of eco-friendly pest control services. The company has earned a reputation for its commitment to keeping homes safe, healthy, and pest-free while also…
More Releases for Prostate
The 3D Urology and Prostate Clinics Introduces Innovative Natural and Targeted P …
The 3D Urology and Prostate Clinics introduces its innovative 3D targeted injection therapies, offering effective, natural solutions for various prostate conditions including prostatitis, enlarged prostate, and prostate cancer.
Renowned for its pioneering approach to prostate health, The 3D Urology and Prostate Clinics is bringing renewed hope to patients worldwide suffering from various prostate diseases. Utilizing advanced diagnostic techniques and a unique targeted injection method, the clinics offer specialized treatments that focus…
The 3D Urology and Prostate Clinics Introduces Advanced 3D Prostate Targeted Tre …
The 3D Urology and Prostate Clinics announces its latest breakthrough in targeted prostate treatment, offering a revolutionary approach to prostate cancer and other prostate-related conditions.
The 3D Urology and Prostate Clinics, renowned for its advanced techniques in prostate health, is proud to present its groundbreaking 3D prostate Targeted Treatment, a comprehensive and non-invasive solution for men suffering from prostate conditions. The clinic's innovative treatment is designed to target the root causes…
The 3D Urology and Prostate Clinics Unveil Innovative 3D Prostate Targeted Treat …
The 3D Urology and Prostate Clinics introduce their groundbreaking 3D prostate targeted treatment, offering a non-invasive solution for prostate health issues.
The 3D Urology and Prostate Clinics, renowned for their specialized treatments in prostate health, are proud to unveil their innovative 3D prostate targeted treatment. This cutting-edge therapy provides a non-invasive, highly effective solution for prostate-related conditions, offering patients a new path to recovery and well-being.Image: https://i.imgur.com/NCfbb6S.jpg
At the heart of this…
The 3D Urology and Prostate Clinics Unveils Advanced 3D prostate Targeted Treatm …
The 3D Urology and Prostate Clinics is at the forefront of prostate care, offering the advanced 3D Targeted Therapy as a precise and effective treatment solution.
The 3D Urology and Prostate Clinics is proud to announce its revolutionary 3D prostate Targeted Treatment [http://www.3dprostatecure.com/page.php?cata_id=19], setting a new standard in prostate care. This highly advanced treatment option utilizes cutting-edge technology to deliver focused treatment, minimizing side effects and enhancing recovery for patients. Men…
3D Prostate Cure: Revolutionizing Prostate Treatment with Targeted Therapy
This news release highlights the 3D Urology and Prostate Clinics' innovative approach to prostate treatment using 3D Targeted Therapy, offering a safe and effective alternative to traditional methods.
As a global leader in men's health, The 3D Urology and Prostate Clinics is committed to providing cutting-edge treatments for various prostate conditions. The clinic is proud to announce its revolutionary 3D Targeted Therapy, offering a new standard in prostate care.
This innovative therapy…
The 3D Urology and Prostate Clinics Enhance Prostate Health with Advanced 3D Pro …
The 3D Urology and Prostate Clinics are revolutionizing prostate care with their comprehensive treatments, including the 3D prostate Targeted Treatment and 3D Targeted Therapy, developed to ensure effective, non-surgical solutions for prostate health issues.
At the forefront of prostate health, The 3D Urology and Prostate Clinics are excited to offer innovative treatments such as the 3D prostate Targeted Treatment and 3D Targeted Therapy. These treatments are part of the clinic's commitment…